Company Unit of A/c Sales 2012 Sales from Vaccines Profit Before Tax Contribution of Vaccines to Op. Profit
      Value % Value %  
Sanofi Mio Euros 34947 3897 11.1 6337 18.1 10.1
GSK Mio Pounds 26431 3325 12.6 7635 28.9 14.0
Merck Mio US $ 47267 1631 3.4 6299 13.3 NA
Pfizer Mio US $ 58986 4117 7.0 12080 20.5 NA
Novartis Mio US $ 56673 1858 3.2 9618 17.0 -0.5
Source: Published Company Annual Reports. NA : Not Available
Table 1: Profitability of Major Companies in the Vaccine Business in 2012